Deerfield Management’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Deerfield Management’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1	Closed	-$10	–	111
2023 Q2	$10	Hold	1	–	–	﹤0.01%	101
2023 Q1	$10	Hold	1	–	–	﹤0.01%	105
2022 Q4	$10	Hold	1	–	–	﹤0.01%	103
2022 Q3	$0	Hold	1	–	–	﹤0.01%	138
2022 Q2	$0	Hold	1	–	–	﹤0.01%	138
2022 Q1	$0	Buy	+1	New	+$10	﹤0.01%	136
2021 Q3	–	Sell	-1,000,000	Closed	-$10M	–	160
2021 Q2	$10M	Hold	1,000,000	–	–	0.18%	115
2021 Q1	$10.1M	Hold	1,000,000	–	–	0.21%	101
2020 Q4	$10.5M	Buy	+1,000,000	New	+$10.4M	0.21%	101

Deerfield Management's MTACU Position: Q3 2023 in Review

Deerfield Management sold out of MedTech Acquisition Corporation Unit (MTACU) in Q3 2023, closing a stake of 1 share — an estimated $10 sold.

Deerfield Management first reported a position in MTACU in Q4 2020 and held it in 9 quarters. The position peaked at $10.5M in Q4 2020. 0 funds tracked by Wall St. Rank hold MTACU as of Q3 2023.

Deerfield Management reported no remaining MedTech Acquisition Corporation Unit position as of Q3 2023 after selling out during the quarter.
Deerfield Management sold 1 MedTech Acquisition Corporation Unit share in Q3 2023, an estimated $10.
Deerfield Management first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 9 quarters.
Deerfield Management's MedTech Acquisition Corporation Unit position peaked at $10.5M in Q4 2020.
0 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q3 2023.

Based on Deerfield Management's 13F filing for Q3 2023, filed 14 Nov 2023.